Pasithea Therapeutics Corp. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur KTTA

Pasithea Therapeutics (KTTA) generates revenue from ketamine infusion therapy at its clinics. The trailing twelve-month sales growth rate visualizes revenue dynamics, while the 0.00 level captures the latest values. The company is implementing bioethical standards and sustainable methods within its laboratories. However, the development of new molecules requires constant investment, which temporarily increases operating expenses until the drugs are commercialized.
Ringkesan rincian data analitis Pasithea Therapeutics (KTTA)

This indicator measures the rate of change in aggregate revenue over the last twelve months, allowing for an assessment of the cash flow's actual resilience to external shocks. An analysis of the TTM revenue growth YoY for Pasithea Therapeutics (KTTA) demonstrates how effectively patent protection and stable demand for the treatment of neurological pathologies are transformed into organic business growth, defining the asset's long-term investment profile.